ABCL AbCellera Biologics Inc. logo

ABCL AbCellera Biologics Inc.

Healthcare
$5.41+0.00%OpenMarket Cap: $1.65B

As of 2026-05-26

Analyst Consensus

Consensus

Buy

Target (Consensus)

$7.50

Target (Median)

$7.50

Target Range

$7.00 - $8.00

Upside from current price: 38.8%

Rating Distribution

1 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
DateFirmActionRatingPrevious
2025-11-07Leerink PartnersdowngradeMarket PerformOutperform
2025-08-08StifelmaintainBuyBuy
2025-07-14KeybancmaintainOverweightOverweight
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.64$30.9M4
Sun Dec 31$-0.82$33.4M5
Mon Dec 31$-0.76$63.9M1
Tue Dec 31$-0.65$124.1M1